262 related articles for article (PubMed ID: 30270169)
1. Surfactant Components and Tracheal Aspirate Inflammatory Markers in Preterm Infants with Respiratory Distress Syndrome.
Verlato G; Simonato M; Giambelluca S; Fantinato M; Correani A; Cavicchiolo ME; Priante E; Carnielli V; Cogo P
J Pediatr; 2018 Dec; 203():442-446. PubMed ID: 30270169
[TBL] [Abstract][Full Text] [Related]
2. Surfactant protein A and saturated phosphatidylcholine in respiratory distress syndrome.
Moya FR; Montes HF; Thomas VL; Mouzinho AM; Smith JF; Rosenfeld CR
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1672-7. PubMed ID: 7952631
[TBL] [Abstract][Full Text] [Related]
3. Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome.
Bae YM; Bae CW; Oh MH; Lee SH; Woo KM; Jung KB
J Perinat Med; 2009; 37(5):561-4. PubMed ID: 19492923
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms to explain surfactant responses.
Jobe AH
Biol Neonate; 2006; 89(4):298-302. PubMed ID: 16770069
[TBL] [Abstract][Full Text] [Related]
5. Does surfactant type cause a differential proinflammatory response in preterm infants with respiratory distress syndrome?
Mercado VV; Cristea I; Ali N; Pham CC; Buescher E; Yang J; Fisher J; Maramreddy H; Calo J; Strassberg S; Parton LA
Adv Ther; 2010 Jul; 27(7):476-82. PubMed ID: 20586001
[TBL] [Abstract][Full Text] [Related]
6. Chorioamnionitis alters lung surfactant lipidome in newborns with respiratory distress syndrome.
Giambelluca S; Verlato G; Simonato M; Vedovelli L; Bonadies L; Najdekr L; Dunn WB; Carnielli VP; Cogo P
Pediatr Res; 2021 Nov; 90(5):1039-1043. PubMed ID: 33531681
[TBL] [Abstract][Full Text] [Related]
7. Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants.
Hallman M; Merritt TA; Akino T; Bry K
Am Rev Respir Dis; 1991 Dec; 144(6):1376-84. PubMed ID: 1741552
[TBL] [Abstract][Full Text] [Related]
8. Surfactant therapy in neonates with respiratory failure due to haemorrhagic pulmonary oedema.
Amizuka T; Shimizu H; Niida Y; Ogawa Y
Eur J Pediatr; 2003 Oct; 162(10):697-702. PubMed ID: 12898240
[TBL] [Abstract][Full Text] [Related]
9. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone therapy in preterm infants developing bronchopulmonary dysplasia: effect on pulmonary surfactant disaturated-phosphatidylcholine kinetics.
Cogo PE; Simonato M; Mariatoffolo G; Stefanutti G; Chierici M; Cobelli C; Ori C; Carnielli VP
Pediatr Res; 2008 Apr; 63(4):433-7. PubMed ID: 18356753
[TBL] [Abstract][Full Text] [Related]
11. [A multicenter study on the surfactant treatment in late-preterm or term infants with respiratory distress syndrome].
Collaborative Study Group for Late-preterm/Term Infants with Respiratory Distress
Zhonghua Er Ke Za Zhi; 2014 Oct; 52(10):724-8. PubMed ID: 25537535
[TBL] [Abstract][Full Text] [Related]
12. Surfactant phospholipids and surface activity among preterm infants with respiratory distress syndrome who develop bronchopulmonary dysplasia.
Kazzi SN; Schürch S; McLaughlin KL; Romero R; Janisse J
Acta Paediatr; 2000 Oct; 89(10):1218-25. PubMed ID: 11083379
[TBL] [Abstract][Full Text] [Related]
13. Prenatal dexamethasone and exogenous surfactant therapy: surface activity and surfactant components in airway specimens.
Kari MA; Akino T; Hallman M
Pediatr Res; 1995 Nov; 38(5):676-84. PubMed ID: 8552433
[TBL] [Abstract][Full Text] [Related]
14. Treatment with exogenous surfactant stimulates endogenous surfactant synthesis in premature infants with respiratory distress syndrome.
Bunt JE; Carnielli VP; Janssen DJ; Wattimena JL; Hop WC; Sauer PJ; Zimmermann LJ
Crit Care Med; 2000 Oct; 28(10):3383-8. PubMed ID: 11057790
[TBL] [Abstract][Full Text] [Related]
15. The surfactant system protects both fetus and newborn.
Hallman M
Neonatology; 2013; 103(4):320-6. PubMed ID: 23736009
[TBL] [Abstract][Full Text] [Related]
16. Metabolic precursors of surfactant disaturated-phosphatidylcholine in preterms with respiratory distress.
Cogo PE; Ori C; Simonato M; Verlato G; Isak I; Hamvas A; Carnielli VP
J Lipid Res; 2009 Nov; 50(11):2324-31. PubMed ID: 19474458
[TBL] [Abstract][Full Text] [Related]
17. Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome.
Wang JY; Yeh TF; Lin YC; Miyamura K; Holmskov U; Reid KB
Thorax; 1996 Sep; 51(9):907-13. PubMed ID: 8984701
[TBL] [Abstract][Full Text] [Related]
18. Improving the prediction of surfactant deficiency in very low-birthweight infants with respiratory distress.
Harker LC; Merritt TA; Edwards DK
J Perinatol; 1992 Jun; 12(2):129-33. PubMed ID: 1522430
[TBL] [Abstract][Full Text] [Related]
19. Phagocyte activation in preterm infants following premature rupture of the membranes or chorioamnionitis.
Nupponen I; Venge P; Pohjavuori M; Lassus P; Andersson S
Acta Paediatr; 2000 Oct; 89(10):1207-12. PubMed ID: 11083377
[TBL] [Abstract][Full Text] [Related]
20. In vivo effect of pneumonia on surfactant disaturated-phosphatidylcholine kinetics in newborn infants.
Facco M; Nespeca M; Simonato M; Isak I; Verlato G; Ciambra G; Giorgetti C; Carnielli VP; Cogo PE
PLoS One; 2014; 9(12):e93612. PubMed ID: 25551219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
